Antimicrobial Action of Chelating Agents: Repercussions on the Microorganism Development, Virulence and Pathogenesis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infections caused by resistant microorganisms often fail to respond to conventional therapy, resulting in prolonged illness, increased treatment costs and greater risk of death. Consequently, the development of novel antimicrobial drugs is becoming more demanding every day since the existing drugs either have too many side-effects or they tend to lose effectiveness due to the selection of resistant strains. In view of these facts, a number of new strategies to obstruct vital biological processes of a microbial cell have emerged; one of these is focused on the use of metal-chelating agents, which are able to selectively disturb the essential metal metabolism of the microorganism by interfering with metal acquisition and bioavailability for crucial reactions. The chelation activity is able to inhibit the biological role of metal-dependent proteins (e.g., metalloproteases and transcription factors), disturbing the microbial cell homeostasis and culminating in the blockage of microbial nutrition, growth and development, cellular differentiation, adhesion to biotic (e.g., extracellular matrix components, cell and/or tissue) and abiotic (e.g., plastic, silicone and acrylic) structures as well as controlling the in vivo infection progression. Interestingly, chelating agents also potentiate the activity of classical antimicrobial compounds. The differences between the microorganism and host in terms of the behavior displayed in the presence of chelating agents could provide exploitable targets for the development of an effective chemotherapy for these diseases. Consequently, metal chelators represent a novel group of antimicrobial agents with potential therapeutic applications. This review will focus on the anti-fungal and anti-protozoan action of the most common chelating agents, deciphering and discussing their mode of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Chemistry and biology of siderophores
Hider, R. C., & Kong, X. (2010) · Natural Product Reports · doi:10.1039/b906679a · Cited by 1,722
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“Candida biofilms have innate resistance and/or tolerance to hard surface disinfectants, metal ions and antifungal drugs in comparison to planktonic suspensions of fungal cells [247].”
BackgroundNovel perspectives on mucormycosis: pathophysiology, presentation, and management
Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.556-569.2005 · Cited by 1,537 · cited 1×
“Clinical and animal data indicate that the presence of elevated available serum iron (like in diabetic ketoacidosis and other systemic acidosis) predisposes the host to mucormycosis by inducing dissociation of iron from sequestering proteins, resulting in elevated available serum iron [194-196].”
BackgroundWeinberg, E. D. (1978) · Microbiological Reviews · doi:10.1128/mmbr.42.1.45-66.1978 · Cited by 1,254
Emerging opportunistic yeast infections
Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70218-8 · Cited by 811 · cited 1×
“and many other less frequent fungal pathogens have come into focus as the cause of devastating clinical diseases[172, 173].”
BackgroundNosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention
Alangaden, G. J. (2011) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.11.003 · Cited by 337
Sundstrom, P. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00206.x · Cited by 336 · cited 1×
“albicans [245].”
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308 · cited 3×
“Most importantly, deferasirox synergistically improved survival and reduced tissue fungal burden when combined with liposomal amphotericin B [200].”
BackgroundEffect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272101 · Cited by 210
Oppenheimer, S. J., Gibson, F. D., Macfarlane, S. B., Moody, J. B., Harrison, C., Spencer, A., & Bunari, O. (1986) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(86)90154-9 · Cited by 205 · cited 1×
“Clinical studies showed that the iron supplementation to iron-deficient individuals causes exacerbation of malaria [132].”
BackgroundMetal ions, Alzheimer's disease and chelation therapy
Budimir, A. (2011) · Acta Pharmaceutica · doi:10.2478/v10007-011-0006-6 · Cited by 202 · cited 2×
“Further applications for chelation therapy have also been postulated as potential alternatives in the prevention/treatment against cardiovascular disease [42, 43], autism [44, 45], diabetes [46], osteoporosis [47, 48], atherosclerosis [49, 50], Parkinson's disease [51, 52] and certain types of cancer [53, 54].”
BackgroundKontoyiannis, D. P., Chamilos, G., Lewis, R. E., Giralt, S., Cortes, J., Raad, I. I., Manning, J. T., & Han, X. (2007) · Cancer · doi:10.1002/cncr.22909 · Cited by 152 · cited 1×
“Transfusional siderosis and iron overload in malignancy and liver and stem cell transplantation are associated with an increased risk of aspergillosis [177-179].”
BackgroundPrasad, T., Chandra, A., Mukhopadhyay, C. K., & Prasad, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00653-06 · Cited by 149 · cited 1×
“In addition, iron deprivation is a mechanism by which drug susceptibility is enhanced in Candida cells by increasing the membrane fluidity (lowering ergosterol content), which in turn leads to enhanced passive diffusion of drugs [184].”
BackgroundIsolation and characterization of a secreted metalloprotease of Aspergillus fumigatus
Monod, M., Paris, S., Sanglard, D., Jaton-Ogay, K., Bille, J., & Latgé, J. P. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4099-4104.1993 · Cited by 141 · cited 1×
“fumigatus, which is able to cleave collagen, was totally inhibited by 1 mM EDTA and 1 mM 1,10-phenanthroline [223]; (ii) an elastinolytic neutral metalloprotease of 43 kDa, which was expressed during the invasion of neutropenic mouse lungs, was fully inhibited by EDTA and 1,10-phenanthroline (at 1 mM) [224]; (iii) a 3…”
BackgroundMajor Surface Protease of Trypanosomatids: One Size Fits All?
Yao, C. (2010) · Infection and Immunity · doi:10.1128/iai.00776-09 · Cited by 105
The transferrin receptor of Trypanosoma brucei
Steverding, D. (2000) · Parasitology International · doi:10.1016/s1383-5769(99)00018-5 · Cited by 81
Zarember, K. A., Cruz, A. R., Huang, C.-Y., & Gallin, J. I. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01547-08 · Cited by 78 · cited 1×
“By means of checkerboard assays, antifungal synergy against conidia was observed for combinations of ketoconazole with ciclopirox or deferiprone, lactoferrin with amphotericin B, and fluconazole with deferiprone [176].”
BackgroundIbrahim, A. S., Gebremariam, T., French, S. W., Edwards, J. E., & Spellberg, B. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp426 · Cited by 68
Role of iron in intracellular growth of Trypanosoma cruzi
Loo, V. G., & Lalonde, R. G. (1984) · Infection and Immunity · doi:10.1128/iai.45.3.726-730.1984 · Cited by 60 · cited 2×
“cruzi were published by Lalonde and Holbein [62] and Loo and Lalonde [61].”
BackgroundMethodIron and virulence in Shigella
Payne, S. M. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00281.x · Cited by 57
Iron Chelation as a Chemotherapeutic Strategy for Falciparum Malaria
Gordeuk, V. R., Thuma, P. E., Brittenham, G. M., Biemba, G., Zulu, S., Simwanza, G., Kalense, P., M'Hango, A., Parry, D., Poltera, A. A., et al. (1993) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.48.193 · Cited by 50
Singh, N., & Sun, H.-Y. (2008) · Liver Transplantation · doi:10.1002/lt.21587 · Cited by 40 · cited 1×
“Iron overload is known to exacerbate many infectious diseases, such as microbe infections [10, 11].”
BackgroundHolbein, B. E., & Mira de Orduña, R. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01956.x · Cited by 36
Iron chelators as anti-infectives; malaria as a paradigm
Cabantchik, Z. I., Moody-Haupt, S., & Gordeuk, V. R. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01401.x · Cited by 29
The Treatment of Malaria with Iron Chelators
Hider, R. C., & Liu, Z. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06162.x · Cited by 26
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Transferrin iron starvation therapy for lethal bacterial and fungal infections
Lin, L., Pantapalangkoor, P., Tan, B., Bruhn, K. W., Ho, T., Nielsen, T., Skaar, E. P., Zhang, Y., Bai, R., Wang, A., et al. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu049 · Cited by 68
Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections
Bruhn, K. W., & Spellberg, B. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.005 · Cited by 48
Cohrt, K. A. O., Marín, L., Kjellerup, L., Clausen, J. D., Dalby-Brown, W., Calera, J. A., & Winther, A.-M. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02024-17 · Cited by 32
Targeting zinc homeostasis to combat Aspergillus fumigatus infections
Vicentefranqueira, R., Amich, J., Laskaris, P., Ibrahim-Granet, O., Latgé, J. P., Toledo, H., Leal, F., & Calera, J. A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00160 · Cited by 27
Metadata
- Authors
- L.S. Santos, A., L. Sodre, C., S. Valle, R., A. Silva, B., A. Abi-chacra, E., V. Silva, L., L. Souza-Goncalves, A., S. Sangenito, L., S. Goncalves, D., O.P. Souza, L., F. Palmeira, V., M. d'Avila-Levy, C., F. Kneipp, L., Kellett, A., McCann, M., & H. Branquinha, M.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-05-01
- Volume
- 19
- Issue
- 17
- Pages
- 2715-2737
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2149784744
- Cited by
- 68
- References
- 28
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.